Genetic basis for predicting response to naltrexone in the treatment of alcohol dependence

被引：11

作者：

Anton, Raymond F. ^{[1
]}

机构：

[1] Ctr Drug & Alcohol Programs, Charleston, SC 29425 USA

来源：

PHARMACOGENOMICS | 2008年 / 9卷 / 06期

关键词：

D O I：

10.2217/14622416.9.6.655

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：655 / 658

页数：4

共 26 条

[1] An evaluation of μ-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence [J].

Anton, Raymond F. ;

Oroszi, Gabor ;

O'Malley, Stephanie ;

Couper, David ;

Swift, Robert ;

Pettinati, Helen ;

Goldman, David .

ARCHIVES OF GENERAL PSYCHIATRY, 2008, 65 (02) :135-144

[2] Combined pharmacotherapies and behavioral interventions for alcohol dependence - The COMBINE study: A randomized controlled trial [J].

Anton, RF ;

O'Malley, SS ;

Ciraulo, DA ;

Cisler, RA ;

Couper, D ;

Donovan, DM ;

Gastfriend, DR ;

Hosking, JD ;

Johnson, BA ;

LoCastro, JS ;

Longabaugh, R ;

Mason, BJ ;

Mattson, ME ;

Miller, WR ;

Pettinati, HM ;

Randall, CL ;

Swift, R ;

Weiss, RD ;

Williams, LD ;

Zweben, A .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (17) :2003-2017

[3] Naltrexone effects on alcohol consumption in a clinical laboratory paradigm: temporal effects of drinking [J].

Anton, RF ;

Drobes, DJ ;

Voronin, K ;

Durazo-Avizu, R ;

Moak, D .

PSYCHOPHARMACOLOGY, 2004, 173 (1-2) :32-40

[4] Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor [J].

Beyer, A ;

Koch, T ;

Schröder, H ;

Schulz, S ;

Höllt, V .

JOURNAL OF NEUROCHEMISTRY, 2004, 89 (03) :553-560

[5] Single-nucleotide polymorphism in the human mu opioid receptor gene alters β-endorphin binding and activity:: Possible implications for opiate addiction [J].

Bond, C ;

LaForge, KS ;

Tian, MT ;

Melia, D ;

Zhang, SW ;

Borg, L ;

Gong, JH ;

Schluger, J ;

Strong, JA ;

Leal, SM ;

Tischfield, JA ;

Kreek, MJ ;

Yu, L .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (16) :9608-9613

[6] Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence:: a systematic review [J].

Carmen, B ;

Angeles, M ;

Ana, M ;

María, AJ .

ADDICTION, 2004, 99 (07) :811-828

[7] Efficacy and tolerability of long-acting injectable for alcohol dependence - A randomized controlled trial [J].

Garbutt, JC ;

Kranzler, HR ;

O'Malley, SS ;

Gastfriend, DR ;

Pettinati, HM ;

Silverman, BL ;

Loewy, JW ;

Ehrich, EW .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (13) :1617-1625

[8] Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence:: Results from the VA cooperative study [J].

Gelernter, Joel ;

Gueorguieva, Ralitza ;

Kranzler, Henry R. ;

Zhang, Huiping ;

Cramer, Joyce ;

Rosenheck, Robert ;

Krystal, John H. .

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2007, 31 (04) :555-563

[9] The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991-1992 and 2001-2002 [J].

Grant, BF ;

Dawson, DA ;

Stinson, FS ;

Chou, SP ;

Dufour, MC ;

Pickering, RP .

DRUG AND ALCOHOL DEPENDENCE, 2004, 74 (03) :223-234

[10] Naltrexone, relapse prevention, and supportive therapy with alcoholics: An analysis of patient treatment matching [J].

Jaffe, AJ ;

Rounsaville, B ;

Chang, G ;

Schottenfeld, RS ;

Meyer, RE ;

OMalley, SS .

JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 1996, 64 (05) :1044-1053

← 1 2 3 →